β-sitosterol combined with GEM exhibits synergistic anti-pancreatic cancer activity by regulating apoptosis and inhibiting epithelial-mesenchymal transition through inhibition of Akt/GSK-3β signaling (Cao et al., 2020). This evidence concerns the gene AKT1 and familial pancreatic carcinoma.